(Q43050851)

13 November 2017

title

HIV-2 capsids distinguish high and low virus load patients in a West African community cohort (English)

1 reference

13 November 2017

author

Aleksandra Leligdowicz

2

1 reference

13 November 2017

Matthew Cotten

13

0 references

Thushan I de Silva

object named as

Thushan de Silva

8

0 references

Clayton O. Onyango

1

object named as

Clayton O Onyango

1 reference

13 November 2017

11

Hilton Whittle

1 reference

13 November 2017

10

Assan Jaye

1 reference

13 November 2017

12

Sarah Rowland-Jones

1 reference

13 November 2017

Masaru Yokoyama

3

1 reference

13 November 2017

Hironori Sato

4

1 reference

13 November 2017

Haihan Song

5

1 reference

13 November 2017

Emi E Nakayama

6

1 reference

13 November 2017

Tatsuo Shioda

7

1 reference

13 November 2017

John Townend

9

1 reference

13 November 2017

language of work or name

English

0 references

publication date

1 May 2010

1 reference

13 November 2017

1 reference

13 November 2017

volume

28 Suppl 2

1 reference

13 November 2017

page(s)

B60-7

1 reference

Serological evidence for virus related to simian T-lymphotropic retrovirus III in residents of west Africa

13 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.08.060

Isolation of a new human retrovirus from West African patients with AIDS.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.08.060

Tracing the origin and history of the HIV-2 epidemic

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.08.060

Out of Africa: what can we learn from HIV-2 about protective immunity to HIV-1?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.08.060

Prevalence of and mortality from human immunodeficiency virus type 2 in Bissau, West Africa

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.08.060

Sequence specificity of the human immunodeficiency virus type 2 (hiv-2) long terminal repeat u3 region in vivo allows subtyping of the principal hiv-2 viral subtypes a and b.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.08.060

Plasma RNA viral load predicts the rate of CD4 T cell decline and death in HIV-2-infected patients in West Africa.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.08.060

The effects of HIV-2 infection in a rural area of Guinea-Bissau.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.08.060

HIV-2 genetic variation and DNA load in asymptomatic carriers and AIDS cases in Guinea-Bissau

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.08.060

Natural variation of the nef gene in human immunodeficiency virus type 2 infections in Portugal.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.08.060

Robust Gag-specific T cell responses characterize viremia control in HIV-2 infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.08.060

High-resolution structure of a retroviral capsid hexameric amino-terminal domain

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.08.060

The Mechanism of HIV-1 Core Assembly: Insights from Three-Dimensional Reconstructions of Authentic Virions

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.08.060

Assembly and analysis of conical models for the HIV-1 core.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.08.060

The structural biology of HIV assembly

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.08.060

Structure of the carboxyl-terminal dimerization domain of the HIV-1 capsid protein

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.08.060

Plasma viral load, CD4 cell percentage, HLA and survival of HIV-1, HIV-2, and dually infected Gambian patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.08.060

A single amino acid of the human immunodeficiency virus type 2 capsid affects its replication in the presence of cynomolgus monkey and human TRIM5alphas

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.08.060

Amino acid 36 in the human immunodeficiency virus type 1 gp41 ectodomain controls fusogenic activity: implications for the molecular mechanism of viral escape from a fusion inhibitor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.08.060

HIV-1 proteases from drug-naive West African patients are differentially less susceptible to protease inhibitors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.08.060

Phosphorylation of APOBEC3G by protein kinase A regulates its interaction with HIV-1 Vif.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.08.060

Mutual conformational adaptations in antigen and antibody upon complex formation between an Fab and HIV-1 capsid protein p24

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.08.060

Protein structure prediction and structural genomics

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.08.060

Force fields for protein simulations

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.08.060

Molecular modeling approach to understanding the mode of action of L-nucleosides as antiviral agents

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.08.060

Genome organization and transactivation of the human immunodeficiency virus type 2.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.08.060

The cytoplasmic body component TRIM5alpha restricts HIV-1 infection in Old World monkeys

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.08.060

HIV: replication trimmed back

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.08.060

A conserved mechanism of retrovirus restriction in mammals

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.08.060

GE Prize-winning essay. Why Old World monkeys are resistant to HIV-1.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.08.060

Cellular inhibitors with Fv1-like activity restrict human and simian immunodeficiency virus tropism

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.08.060

Specific recognition and accelerated uncoating of retroviral capsids by the TRIM5alpha restriction factor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.08.060

Structural insights into the catalytic mechanism of cyclophilin A

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.08.060

Low level viremia and high CD4% predict normal survival in a cohort of HIV type-2-infected villagers

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.08.060

Evidence of HIV-1 adaptation to HLA-restricted immune responses at a population level

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.08.060

Human leukocyte antigen-specific polymorphisms in HIV-1 Gag and their association with viral load in chronic untreated infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.08.060

Founder Effects in the Assessment of HIV Polymorphisms and HLA Allele Associations

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.08.060

Adaptation of HIV-1 to human leukocyte antigen class I

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.08.060

AIDS/HIV. Finding footprints among the trees

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.08.060

A simple method for estimating evolutionary rates of base substitutions through comparative studies of nucleotide sequences

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.08.060

MEGA4: Molecular Evolutionary Genetics Analysis (MEGA) Software Version 4.0

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.08.060

Prospects for inferring very large phylogenies by using the neighbor-joining method

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.08.060

The epidemiology of HIV infection in a rural area of Guinea-Bissau.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.08.060

Mortality among human immunodeficiency virus type 2-positive villagers in rural Guinea-Bissau is correlated with viral genotype

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.08.060

inferred from DOI database lookup

7 January 2021

based on heuristic

Role of the major homology region of human immunodeficiency virus type 1 in virion morphogenesis.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.08.060

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/J.VACCINE.2009.08.060

1 reference

13 November 2017

1 reference